Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Amyloidosis × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Completed 12 Recruiting 2 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 380 Breast Neoplasms 362 Colorectal Neoplasms 235 Stomach Neoplasms 216 Carcinoma, Hepatocellular 156 Lung Neoplasms 122 Neoplasms 120 Pancreatic Neoplasms 105 Prostatic Neoplasms 97 Neoplasm Metastasis 96 Recurrence 94 Rectal Neoplasms 93 Ovarian Neoplasms 91 Nasopharyngeal Carcinoma 88 Esophageal Squamous Cell Carcinoma 80 Esophageal Neoplasms 80 Lymphoma, Large B-Cell, Diffuse 79 Melanoma 75 Small Cell Lung Carcinoma 71 Lymphoma 70 Leukemia, Myeloid, Acute 70 Uterine Cervical Neoplasms 69 Head and Neck Neoplasms 69 Brain Neoplasms 69 Sarcoma 68 Squamous Cell Carcinoma of Head and Neck 67 Multiple Myeloma 65 Carcinoma, Renal Cell 62 Triple Negative Breast Neoplasms 59 Lymphoma, Non-Hodgkin 55

Interventions

pomalidomide 1 isatuximab 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡